President and Chief Executive Officer
United States of America
Jigar Raythatha has spent nearly 20 years in the biotechnology industry in a variety of business functions. He rejoined Constellation in May 2017 from Jounce Therapeutics, where he held the role of chief business officer. He was the first employee at Jounce and helped build the company from its inception to a 100-person, publicly traded research and development organization. Previously, he served as head of corporate development at Constellation, where he led business development, strategy and program and alliance management functions. Prior to Constellation, Mr. Raythatha worked with Red Abbey Venture Partners, initially as a Kauffman fellow, later as a principal and finally a venture partner. Earlier in his career, Mr. Raythatha held roles of increasing responsibility at Biogen and A.T. Kearney. He earned a Master of Business Administration from Columbia University and a Bachelor of Arts in biochemistry and economics from Rutgers University.
Advancing novel, small molecule treatments targeting epigenetic mechanisms in tumor and immune cells